Facilitation of Enrollment onto Cancer Clinical Trials Using a Novel Navigator-Assisted Program: A Cross-Sectional Study

被引:0
|
作者
Hossami, Mahmoud [1 ]
Abdel-Nabi, Rhonda [1 ]
Zaib, Farwa [2 ]
Touma, Kayla [1 ]
Nassar, Renee [2 ]
Rim, Sanghyuk Claire [2 ]
Paunic, Milica [1 ]
Hilal, Olla [2 ]
Gupta, Pratham [2 ]
Hirmiz, Roaa [3 ]
Touma, Michael [4 ]
Sadik, Govana [1 ]
Akingbade, Emmanuel [1 ]
Sharma, Depen [1 ]
Kalia, Swati [2 ]
Fatima, Rija [1 ]
Luginaah, Anthony [2 ]
Mohamed, Ibrahim [2 ]
Luo, Rong [1 ]
Delisle, Megan [5 ,6 ]
Hamm, Caroline [1 ,2 ,3 ]
机构
[1] Univ Windsor, Fac Biomed Sci, Windsor, ON N9B 3P4, Canada
[2] Western Univ, Dept Oncol, Windsor Campus, Windsor, ON N8W 2X3, Canada
[3] Clin Trials Navigator Inc, Windsor, ON N8W 2X3, Canada
[4] Griffith Univ, Sch Med, Gold Coast, Qld 4111, Australia
[5] Univ Manitoba, Dept Surg, Winnipeg, MB R3E 0V9, Canada
[6] Paul Albrechtsen CancerCare Manitoba Res Inst, Winnipeg, MB R3E 0V9, Canada
关键词
clinical trials accrual; navigator; cancer; CENTERS PROGRAM; PATIENT; PARTICIPATION; PHYSICIAN; INTERNET; SEARCH; SYSTEM; IMPACT;
D O I
10.3390/curroncol31110526
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: Clinical trials are essential to the advancement of clinical therapies that improve the outcomes of people with cancer. However, enrollment in clinical trials remains a challenge. The Clinical Trial Navigator [CTN] Program was designed to address the current gap in the cancer care journey by assisting with the clinical trials search process. Methods: Between March 2019 and July 2024, applicants of the CTN program included people with cancer, their family members, and/or their care team. Applicants entered the CTN program through a REDCap (R) survey that collected the patient's medical history. A final curated list of potential clinical trials was provided to the applicant. Metrics of success included clinical trial referral and enrollment, and we examined the factors that impacted these outcomes. Results: A total of 445 people with cancer applied to the CTN program during the study. Of the 262 patients with referral and enrollment information, a trial referral occurred in 27.5% [n = 72]. Of the 72 patients who were referred to a clinical trial, 13 [18.1%] were enrolled, 9 [12.5%] are pending enrollment, and 50 [69.4%] were not enrolled. We identified a potential trial for 88% of applicants, with a median of one potential trial per patient. Physicians were highly involved as applicants. Interpretation: The CTN program is successful in searching for clinical trials for people with cancer. Ongoing implementation into other Canadian sites, assessments of patient-reported outcomes, website and social media campaigns, and research into the factors that impact referral and enrollment are underway.
引用
收藏
页码:7144 / 7154
页数:11
相关论文
共 50 条
  • [21] Relationship between clinical trials and disease burden of India: A cross-sectional study
    Kaur, Rimplejeet
    Charan, Jaykaran
    Reljic, Tea
    Singh, Surjit
    Bhardwaj, Pankaj
    Tsalatsanis, Athanasios
    Kumar, Ambuj
    JOURNAL OF PHARMACY AND BIOALLIED SCIENCES, 2020, 12 (03): : 269 - 276
  • [22] Trends in ethnoracial representation in alopecia areata clinical trials: a cross-sectional study
    Jin, Joy
    Elhage, Kareem
    Spencer, Riley
    Davis, Mitchell
    Hakimi, Marwa
    Bhutani, Tina
    Liao, Wilson
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB243 - AB243
  • [23] Registered clinical trials on addiction: a cross-sectional study on ClinicalTrials.gov
    Liu, Guina
    Chen, Lingmin
    Yang, Yi
    Zhang, Yonggang
    Luo, Shanxia
    JOURNAL OF ADDICTIVE DISEASES, 2022, 40 (03) : 394 - 404
  • [24] A cross-sectional study of ethnoracial representation in pediatric plaque psoriasis clinical trials
    Mosca, Megan
    Hong, Julie
    Hadeler, Edward
    Hakimi, Marwa
    Brownstone, Nicholas
    Bhutani, Tina
    Liao, Wilson
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 86 (02) : 442 - 444
  • [25] Registered Clinical Trials Comprising Pregnant Women in China: A Cross-Sectional Study
    Zhao, Yi
    Du, Guiping
    Luan, Xiaofei
    Yang, Hui
    Zhang, Qiongguang
    Zhang, Zhengfu
    Wang, Subiao
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [26] Knowledge of and attitudes toward clinical trials in Saudi Arabia: a cross-sectional study
    Al-Rawashdeh, Nedal
    Damsees, Rana
    Al-Jeraisy, Majed
    Al Qasim, Eman
    Deeb, Ahmad M.
    BMJ OPEN, 2019, 9 (10):
  • [27] Quality of informed consent in cancer clinical trials in India: A cross-sectional survey.
    Gota, Vikram
    Nookala, Manjunath
    Yadav, Akanksha
    Kannan, Sadhna
    Ali, Raghib
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [28] Publication of neurology clinical trials registered with clinical trial registry of India: A cross-sectional study
    Mishra, Biswamohan
    Agarwal, Ayush
    Nilima, Nilima
    Srivastava, M. V. Padma
    Vishnu, Venugopalan Y.
    ACTA NEUROLOGICA SCANDINAVICA, 2022, 146 (05): : 475 - 484
  • [29] Evaluating stress, satisfaction and the associated influencing factors of participants in cancer clinical trials: a cross-sectional study in China
    Jiang, Shiyu
    Liu, Peng
    Yang, Sheng
    Yang, Jianliang
    Wu, Dawei
    Fang, Hong
    Qin, Yan
    Zhou, Shengyu
    Xu, Jianping
    Sun, Yongkun
    Mo, Hongnan
    Gui, Lin
    Xing, Puyuan
    Lan, Bo
    Zhang, Bo
    Tang, Le
    Sun, Yan
    Shi, Yuankai
    BMJ OPEN, 2019, 9 (05):
  • [30] Impact of informed consent quality on illness uncertainty among patients with cancer in clinical trials: A cross-sectional study
    Kang, Sihan
    Zhang, Jie
    Pang, Dong
    Yang, Hong
    Liu, Xiaohong
    Guo, Renxiu
    Lu, Yuhan
    ASIA-PACIFIC JOURNAL OF ONCOLOGY NURSING, 2025, 12